Facial Paralysis
21
3
4
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.8%
1 terminated out of 21 trials
91.7%
+5.2% vs benchmark
5%
1 trials in Phase 3/4
9%
1 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (21)
Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis
Kabat Rehabilitation Versus Kinesiology Taping in Bell's Palsy
Roy Adaptation Model Improves Mood and QOL After Giant Acoustic Neuroma
Mindfulness in Nonflaccid Facial Paralysis
Intraoperative Electrical Stimulation to Improve Nerve Grafting Outcome
The Effect Vitamin D on the Recovery Rate of Bell Palsy
3D Dynamic and Patient-Centered Outcomes of Facial Reanimation Surgery in Patients With Facial Paralysis
Eye Soft Surgery for Facial Sinkynesis
Artificial Eye Blinking Stimulation Following Paralysis of the Facial Nerve
Neurotomy to Treat Synkinesis Following Peripheral Facial Palsy
A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair.
Morphometric Study of the Muscles of the Skin in MRI 3 Tesla in Patients With Facial Paralysis.
Photobiomodulation Therapy Treatment on Facial Paralysis
Outcome of Facial Palsy Following Rehabilitation
Free Neurovascularized Muscle Transfer in Facial Reanimation of Long-standing Facial Palsy Patients
Effects of Mindfulness Meditation on Facial Paralysis Patients
Magnetic Correction of Eye Lid Paralysis
Function and Form Outcomes in Patients With Facial Paralysis
Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors
Microbiologic Findings of Acute Facial Palsy in Children